85.81
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$84.73
Aprire:
$84.84
Volume 24 ore:
9.16M
Relative Volume:
1.37
Capitalizzazione di mercato:
$69.17B
Reddito:
$20.10B
Utile/perdita netta:
$3.04B
Rapporto P/E:
24.04
EPS:
3.569
Flusso di cassa netto:
$3.44B
1 W Prestazione:
+1.74%
1M Prestazione:
+8.57%
6M Prestazione:
-3.26%
1 anno Prestazione:
-1.99%
Colgate Palmolive Co Stock (CL) Company Profile
Nome
Colgate Palmolive Co
Settore
Industria
Telefono
(212) 310-2000
Indirizzo
300 PARK AVE, NEW YORK, NY
Confronta CL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CL
Colgate Palmolive Co
|
85.81 | 68.30B | 20.10B | 3.04B | 3.44B | 3.569 |
|
PG
Procter Gamble Co
|
149.93 | 341.30B | 84.93B | 16.86B | 14.94B | 6.8506 |
|
UL
Unilever Plc Adr
|
65.53 | 141.37B | 64.99B | 6.71B | 6.53B | 2.74 |
|
EL
Estee Lauder Cos Inc
|
119.49 | 42.48B | 14.42B | -930.00M | 1.05B | -2.5832 |
|
KVUE
Kenvue Inc
|
17.75 | 33.30B | 15.01B | 1.43B | 1.63B | 0.744 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-13 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2026-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-12-11 | Downgrade | Argus | Buy → Hold |
| 2025-12-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-03 | Ripresa | Piper Sandler | Neutral |
| 2024-10-28 | Downgrade | Stifel | Buy → Hold |
| 2024-09-24 | Iniziato | Piper Sandler | Overweight |
| 2024-09-16 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2024-09-09 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-07-26 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-07-24 | Downgrade | Jefferies | Buy → Hold |
| 2024-07-23 | Iniziato | TD Cowen | Buy |
| 2024-06-24 | Iniziato | Exane BNP Paribas | Outperform |
| 2024-03-01 | Ripresa | Goldman | Buy |
| 2024-01-29 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-12-15 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-11-13 | Iniziato | Jefferies | Buy |
| 2023-10-16 | Aggiornamento | Stifel | Hold → Buy |
| 2023-09-22 | Iniziato | HSBC Securities | Buy |
| 2023-02-17 | Iniziato | Citigroup | Buy |
| 2023-01-30 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-22 | Iniziato | Wolfe Research | Peer Perform |
| 2022-10-13 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-08-01 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-05-03 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-04-08 | Iniziato | Raymond James | Mkt Perform |
| 2022-02-02 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2022-01-31 | Reiterato | Citigroup | Neutral |
| 2022-01-31 | Reiterato | Credit Suisse | Outperform |
| 2022-01-31 | Reiterato | Deutsche Bank | Buy |
| 2022-01-31 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-01-31 | Reiterato | Wells Fargo | Underweight |
| 2021-12-16 | Iniziato | Redburn | Neutral |
| 2021-10-05 | Ripresa | BofA Securities | Neutral |
| 2021-09-20 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2021-06-24 | Iniziato | UBS | Buy |
| 2021-06-09 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-02-01 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2021-01-28 | Downgrade | Stifel | Buy → Hold |
| 2021-01-26 | Aggiornamento | Berenberg | Sell → Hold |
| 2021-01-20 | Iniziato | Bernstein | Underperform |
| 2021-01-04 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-08 | Iniziato | Wells Fargo | Underweight |
| 2020-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-03-27 | Aggiornamento | Stifel | Hold → Buy |
| 2020-03-27 | Aggiornamento | SunTrust | Hold → Buy |
| 2020-03-23 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-20 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-02-03 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2020-02-03 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-12-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-10-16 | Iniziato | Berenberg | Sell |
| 2019-04-29 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2019-03-07 | Iniziato | Credit Suisse | Underperform |
| 2019-02-11 | Aggiornamento | Exane BNP Paribas | Underperform → Neutral |
| 2019-01-11 | Iniziato | Evercore ISI | Outperform |
| 2019-01-09 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-10-29 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Downgrade | SunTrust | Buy → Hold |
| 2018-07-30 | Downgrade | Macquarie | Outperform → Neutral |
| 2018-05-25 | Aggiornamento | Argus | Hold → Buy |
| 2018-04-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Mostra tutto
Colgate Palmolive Co Borsa (CL) Ultime notizie
Colgate-Palmolive stock maintains Buy rating at UBS ahead of earnings - Investing.com
How Colgate-Palmolive’s WHO Foundation Oral Health Push At Colgate-Palmolive (CL) Has Changed Its Investment Story - simplywall.st
Did Colgate-Palmolive’s (CL) WHO Oral Health Alliance Just Recast Its Sustainability Investment Narrative? - Yahoo Finance
Colgate-Palmolive and WHO Foundation Announce Global Partnership on Oral Health - 뉴스와이어
Ex-Dividend Reminder: Colgate-Palmolive, Lowe's Companies and CVS Health - Nasdaq
3.7 billion affected by oral disease; Colgate backs 4-year WHO campaign - Stock Titan
Colgate-Palmolive India Schedules Board Meeting for January 29, 2026 to Approve Q3FY26 Financial Results - scanx.trade
Barclays Raises Colgate (CL) Target to $83 but Stays Cautious on Fundamentals - Finviz
Market Trading Guide: Buy Ashok Leyland, Polycab India and 2 more stocks on Tuesday for up to 12% upside - The Economic Times
Campbell & CO Investment Adviser LLC Buys New Holdings in Colgate-Palmolive Company $CL - MarketBeat
The Truth About Colgate-Palmolive: Why Everyone Is Suddenly Watching This ‘Boring’ Stock - AD HOC NEWS
Colgate-Palmolive Co (CL) Stock Price, Trades & News - GuruFocus
JP Morgan Raises Price Target for Colgate-Palmolive (CL) to $93 - GuruFocus
Colgate-Palmolive (NYSE:CL) Price Target Raised to $93.00 at JPMorgan Chase & Co. - MarketBeat
Colgate-Palmolive to stream 2025 earnings call investors can replay - Stock Titan
Barclays Adjusts Price Target on Colgate-Palmolive to $83 From $80, Maintains Equalweight Rating - marketscreener.com
Household Products Stocks Q3 Teardown: Colgate-Palmolive (NYSE:CL) Vs The Rest - Finviz
Colgate-Palmolive Company $CL Stake Raised by Alliance Wealth Management Group - MarketBeat
Colgate-Palmolive flosses away dental care shadows to reveal 'the sweet truth' - Campaign India
$332M Colgate-Palmolive Pension Deal Nabs Final Nod - Law360
Colgate-Palmolive Cleared for $332 Million Pension Class Deal - Bloomberg Law News
Manning & Napier Advisors LLC Sells 35,021 Shares of Colgate-Palmolive Company $CL - MarketBeat
Palmolive Duschgel Review: The Surprisingly Affordable Shower Upgrade Everyone’s Sleeping On - AD HOC NEWS
UBS Maintains Colgate-Palmolive (CL) Rating and Raises Price Tar - GuruFocus
TD Cowen is Bullish on Colgate-Palmolive Company (CL) - Finviz
Colgate-Palmolive (NYSE:CL) Upgraded to Equal Weight at Wells Fargo & Company - MarketBeat
Ranking of most iconic U.S. companies includes 3 in Ohio - cleveland.com
TD Private Client Wealth LLC Has $2.93 Million Stock Position in Colgate-Palmolive Company $CL - MarketBeat
Is Colgate (CL) Turning Emerging-Market Social Impact Into a Durable Brand and Margin Advantage? - simplywall.st
Colgate-Palmolive’s Integrated CSR and ESG Initiatives Create an Impact on Health, Dignity and Community Well-Being - The Hindu
Wells Fargo Upgrades Colgate-Palmolive (CL) - Nasdaq
Analysts See Value Emerging in Colgate-Palmolive Shares - AD HOC NEWS
Demystifying Colgate-Palmolive: Insights From 13 Analyst Reviews - Benzinga
7 Best Beauty Stocks to Buy Right Now - Insider Monkey
Is Colgate's Cost Discipline Enough in a Softer Demand Cycle? - Nasdaq
Colgate-Palmolive emerges from difficult 2025 with a balanced risk/reward -- Wells Fargo (CL:NYSE) - Seeking Alpha
Colgate-Palmolive (CL): Wells Fargo Upgrades to Equal-Weight wit - GuruFocus
Liberty One Investment Management LLC Has $6.48 Million Position in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive's Integrated CSR and ESG Initiatives Create an Impact on Health, Dignity and Community Well-Being - Business Standard
Nordea Investment Management AB Lowers Position in Colgate-Palmolive Company $CL - MarketBeat
Sumitomo Mitsui Trust Group Inc. Purchases 38,836 Shares of Colgate-Palmolive Company $CL - MarketBeat
Wells Fargo Upgrades Colgate-Palmolive to Equalweight From Underweight, Adjusts PT to $86 From $77 - marketscreener.com
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Has $6.48 Million Stake in Colgate-Palmolive Company $CL - MarketBeat
Towercrest Capital Management Boosts Stock Position in Colgate-Palmolive Company $CL - MarketBeat
Colgate Sensation White Review: The Everyday Toothpaste That Wants to Be Your At?Home Whitening Hack - AD HOC NEWS
Another class action claims Tom’s of Maine toothpaste contaminated with bacteria - Class Action Lawsuits
Piper Sandler Sees Colgate (CL) Reaccelerating in 2026, Lifts Price Target - Finviz
Sumitomo Mitsui DS Asset Management Company Ltd Purchases 27,943 Shares of Colgate-Palmolive Company $CL - MarketBeat
Oregon Public Employees Retirement Fund Has $7.39 Million Stock Position in Colgate-Palmolive Company $CL - MarketBeat
An HR exec at $62 billion giant Colgate says Gen Zers are actually ‘pushing us to get better’ - Fortune
Colgate-Palmolive Western Europe legal director Barbara Naouri on resilience, AI and assessing external counsel - Legal Business
Colgate Palmolive Co Azioni (CL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):